CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage biopharmaceutical company developing a new category of therapies for immune-mediated diseases based on defined bacterial ...

In the single-center PREMIX clinical trial, most renal transplant recipients were negative for multidrug-resistant pathogens shortly after receiving fecal microbiota transplants (FMT), with longer ...

Infections caused by multidrug-resistant organisms (MDROs) have dramatically increased in all parts of the world in the past decade. Antibiotic resistance, or the “silent tsunami,” occurs when germs ...

Clostridium difficile infections in the hospital setting have the biggest treatment price tag, researchers say. Infections linked to multidrug-resistant organisms (MDROs) cause a significant cost ...

A regional collaborative involving universal decolonization in long-term care facilities and targeted decolonization among hospital patients in contact precautions is associated with better ...

A seismic demographic shift is afoot, with older adults expected to outnumber children by the year 2034 for the first time in U.S. history. This will result in higher demand for long-term care ...

Please provide your email address to receive an email when new articles are posted on . Antibiotic prophylaxis of spontaneous bacterial peritonitis is less effective in cirrhotic patients with known ...

For decades, hospitals have worked to get staff to wash their hands and prevent the spread of germs. But a new study suggests they may want to expand those efforts to their patients, too. Fourteen ...